Apimeds Pharmaceuticals US Inc’s filing revealed that its Chairman and CMO Kim Christopher acquired Company’s shares for reported $35981.0 on May 13 ’25. In the deal valued at $1.82 per share,19,770 shares were bought. As a result of this transaction, Kim Christopher now holds 19,770 shares worth roughly $39342.3.
Then, Kim Christopher bought 7,730 shares, generating $14,378 in total proceeds. Upon buying the shares at $1.86, the Chairman and CMO now owns 27,500 shares.
Before that, Koo Jakap bought 28,500 shares. Apimeds Pharmaceuticals US Inc shares valued at $56,715 were divested by the Director at a price of $1.99 per share. As a result of the transaction, Koo Jakap now holds 643,885 shares, worth roughly $1.28 million.
Price Performance Review of APUS
On Tuesday, Apimeds Pharmaceuticals US Inc [AMEX:APUS] saw its stock fall -5.24% to $1.99. Over the last five days, the stock has gained 12.43%. Nevertheless, the stocks have fallen -9.55% over the past one year.
Levels Of Support And Resistance For APUS Stock
The 24-hour chart illustrates a support level at 1.79, which if violated will result in even more drops to 1.60. On the upside, there is a resistance level at 2.20. A further resistance level may holdings at 2.42.
How much short interest is there in Apimeds Pharmaceuticals US Inc?
A steep rise in short interest was recorded in Apimeds Pharmaceuticals US Inc stocks on 2025-06-30, dropping by 2025.0 shares to a total of 1191.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-05-30 was 3216.0 shares. There was a decline of -170.03%, which implies that there is a negative sentiment for the stock.
